Breaking News Instant updates and real-time market news.

GILD

Gilead

$77.24

-0.79 (-1.01%)

12:21
10/05/16
10/05
12:21
10/05/16
12:21

Gilead's Sovaldi could face generics in Europe after ruling, STAT News says

The European Patent Office has revoked four of six patent claims related to Gilead's Sovaldi hepatitis C treatment, meaning the medicine could face generic competition years sooner than had been expected, reported STAT News. Reference Link

  • 06

    Nov

  • 11

    Nov

GILD Gilead
$77.24

-0.79 (-1.01%)

09/27/16
LEER
09/27/16
DOWNGRADE
Target $94
LEER
Market Perform
Gilead downgraded to Market Perform from Outperform at Leerink
Leerink analyst Geoffrey Porges downgraded Gilead Sciences to Market Perform from Outperform and lowered his price target for the shares to $94 from $112. The biotech closed yesterday down 75c to $80.62. The analyst says he's now "outright bearish" on the company's Hepatitis C virus business. Gilead's HCV revenues will "decline faster, and farther," than the current consensus estimates forecast, Porges tells investors in a research note.
09/27/16
09/27/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Gilead (GILD) downgraded to Market Perform from Outperform at Leerink with analyst Geoffrey Porges saying he's now "outright bearish" on the company's Hepatitis C virus business. 2. J.M. Smucker (SJM) downgraded to Neutral from Outperform at Credit Suisse with analyst Robert Moskow saying that while the company raised its cost savings target as expected, he underestimated the hit to sales from difficult comparisons. 3. Discovery (DISCA) and Scripps Networks (SNI) downgraded to Sell from Neutral at MoffettNathanson. 4. Carter's (CRI) downgraded to Market Perform from Outperform at Wells Fargo with analyst Ike Boruchow saying his quarter-to-date store checks indicate "choppy" retail traffic trends and "deeper" pricing/promotional pressure. 5. Dollar Tree (DLTR) downgraded to Underweight from Neutral at Atlantic Equities with analyst Sam Hudson saying the second half comp inflection expected by consensus is "too demanding" and he expects multiple contraction if Family Dollar does not turn around. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
LEER
10/03/16
NO CHANGE
LEER
Market Perform
AASLD abstracts hint at potential competitive threat to Gilead HCV, says Leerink
Leerink analyst Geoffrey Porges says abstracts for the American Association for the Study of Liver Diseases, or AASLD, meeting revealed very limited efficacy information about the new Hepatitis C regimens for Gilead (GILD), Merck (MRK) and AbbVie (ABBV). Nonetheless, the analyst believes the abstracts hint at the potential competitive threat to Gilead's HCV dominance. While the new 12-week HCV regimens may compete on price, the forthcoming 8-week regimens put the most pressure on Gilead's market share, Porges argues. He reiterates a Market Perform rating on Gilead's shares.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $95
RBCM
Outperform
Gilead HIV franchise could see risk from competitor data, says RBC Capital
RBC Capital analyst Michael Yee said his conversations with doctors leads him to think two dolutegravir HIV "doublet" studies being conducted by GlaxoSmithKline (GSK) and ViiV Healthcare - Glaxo's joint venture with Pfizer (PFE) and Shionogi - are likely to work and present an underappreciated risk to Gilead's (GILD) HIV franchise. Talks with investors lead Yee to believe few are even aware of this risk and that the consensus view is underestimating the probability these non-inferiority trials will work. Arguing that the consensus view should factor in more conservative assumptions for Gilead's HIV business post 2018 due to this risk, Yee cut his price target on Gilead to $95 from $105, but keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

ORCL

Oracle

$44.72

-0.125 (-0.28%)

12:21
04/25/17
04/25
12:21
04/25/17
12:21
Hot Stocks
Oracle NetSuite announces 'massive' expansion plan »

Oracle NetSuite Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BOX

Box

$16.98

-0.03 (-0.18%)

12:17
04/25/17
04/25
12:17
04/25/17
12:17
Hot Stocks
Box introduces flexible, subscription-based pricing for Box Platform »

Box announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
04/25/17
04/25
12:17
04/25/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
04/25/17
04/25
12:16
04/25/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$30.03

-0.19 (-0.63%)

, CNCE

Concert Pharmaceuticals

$16.08

0.38 (2.42%)

12:13
04/25/17
04/25
12:13
04/25/17
12:13
Hot Stocks
Aclaris Therapeutics given $5 price target in short report »

Art Doyle tweeted out to…

ACRS

Aclaris Therapeutics

$30.03

-0.19 (-0.63%)

CNCE

Concert Pharmaceuticals

$16.08

0.38 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 06

    Jun

PG

Procter & Gamble

$90.00

0.4501 (0.50%)

, PEP

PepsiCo

$114.43

0.11 (0.10%)

12:12
04/25/17
04/25
12:12
04/25/17
12:12
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$90.00

0.4501 (0.50%)

PEP

PepsiCo

$114.43

0.11 (0.10%)

BA

Boeing

$183.29

1.23 (0.68%)

UTX

United Technologies

$116.85

0.53 (0.46%)

TMO

Thermo Fisher

$158.74

1.4 (0.89%)

GD

General Dynamics

$191.83

-0.085 (-0.04%)

ANTM

Anthem

$172.26

3.845 (2.28%)

NOC

Northrop Grumman

$248.59

-0.55 (-0.22%)

WM

Waste Management

$74.54

0.44 (0.59%)

IR

Ingersoll-Rand

$85.18

0.99 (1.18%)

DPS

Dr Pepper Snapple

$98.25

-0.0006 (-0.00%)

HES

Hess Corp.

$48.27

0.61 (1.28%)

WYN

Wyndham

$92.30

0.505 (0.55%)

FLIR

FLIR Systems

$37.24

0.87 (2.39%)

NDAQ

Nasdaq

$70.45

0.54 (0.77%)

STT

State Street

$80.63

0.84 (1.05%)

APH

Amphenol

$72.38

0.45 (0.63%)

ROK

Rockwell Automation

$159.38

2.43 (1.55%)

BAX

Baxter

$53.14

-0.315 (-0.59%)

NSC

Norfolk Southern

$117.09

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 11

    May

  • 17

    May

  • 18

    May

  • 31

    May

  • 06

    Jun

  • 15

    Jun

CHRW

C.H. Robinson

$77.59

1.05 (1.37%)

, CMG

Chipotle

$472.00

3.21 (0.68%)

12:11
04/25/17
04/25
12:11
04/25/17
12:11
Earnings
Notable companies reporting after market close »

Notable companies…

CHRW

C.H. Robinson

$77.59

1.05 (1.37%)

CMG

Chipotle

$472.00

3.21 (0.68%)

COF

Capital One

$85.41

0.725 (0.86%)

DFS

Discover

$67.05

0.135 (0.20%)

EW

Edwards Lifesciences

$98.36

0.4 (0.41%)

ILMN

Illumina

$180.20

4.91 (2.80%)

JNPR

Juniper

$28.15

-0.125 (-0.44%)

SYK

Stryker

$135.76

1.31 (0.97%)

T

AT&T

$40.00

-0.02 (-0.05%)

TSS

TSYS

$54.40

0.59 (1.10%)

TXN

Texas Instruments

$81.08

1.27 (1.59%)

UHS

Universal Health

$121.51

0.605 (0.50%)

WYNN

Wynn Resorts

$115.57

-0.33 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 03

    May

  • 03

    May

  • 04

    May

  • 09

    May

  • 16

    May

  • 17

    May

  • 25

    May

  • 31

    May

  • 06

    Jun

  • 08

    Jun

MLCO

Melco Resorts & Entertainment

$20.75

0.2 (0.97%)

12:11
04/25/17
04/25
12:11
04/25/17
12:11
Options
Bullish flow in Melco Resorts and Entertainment »

Bullish flow in Melco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$34.02

1.41 (4.32%)

12:06
04/25/17
04/25
12:06
04/25/17
12:06
Options
Sarepta call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$66.54

0.44 (0.67%)

, PRGO

Perrigo

$67.28

0.23 (0.34%)

12:05
04/25/17
04/25
12:05
04/25/17
12:05
Hot Stocks
Greenlight goes long Perrigo, Conduent, closes Signet short »

David Einhorn's…

SIG

Signet Jewelers

$66.54

0.44 (0.67%)

PRGO

Perrigo

$67.28

0.23 (0.34%)

GM

General Motors

$33.85

-0.065 (-0.19%)

RAD

Rite Aid

$3.89

0.1558 (4.18%)

WBA

Walgreens Boots Alliance

$84.28

0.25 (0.30%)

CNDT

Conduent

$15.94

-0.02 (-0.13%)

LYB

LyondellBasell

$87.27

0.75 (0.87%)

RES

RPC, Inc.

$17.62

0.07 (0.40%)

AER

AerCap

$45.40

0.31 (0.69%)

BAYRY

Bayer

$118.05

4.95 (4.38%)

CNX

CONSOL

$15.59

0.19 (1.23%)

AAPL

Apple

$143.64

1.37 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 28

    Apr

  • 28

    Apr

  • 02

    May

  • 02

    May

  • 03

    May

  • 09

    May

  • 09

    May

  • 31

    May

  • 26

    Jun

MCD

McDonald's

$140.45

6.215 (4.63%)

11:58
04/25/17
04/25
11:58
04/25/17
11:58
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

AAPL

Apple

$143.64

1.37 (0.96%)

11:58
04/25/17
04/25
11:58
04/25/17
11:58
Hot Stocks
Einhorn's Greenlight continues to like Apple shares »

David Einhorn's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

11:55
04/25/17
04/25
11:55
04/25/17
11:55
General news
Treasury's bill auctions were mixed with the shorter tranche outperforming »

Treasury's bill…

S

Sprint

$8.85

0.135 (1.55%)

11:51
04/25/17
04/25
11:51
04/25/17
11:51
Options
Sizable put buyer in Sprint »

Sizable put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

11:50
04/25/17
04/25
11:50
04/25/17
11:50
General news
U.S. equities extended their rally »

U.S. equities extended…

SIG

Signet Jewelers

$66.07

-0.03 (-0.05%)

11:47
04/25/17
04/25
11:47
04/25/17
11:47
Technical Analysis
Signet Jewelers ticks up off recent lows »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$878.93

19.98 (2.33%)

11:46
04/25/17
04/25
11:46
04/25/17
11:46
Options
Alphabet Class A call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$140.47

6.24 (4.65%)

11:46
04/25/17
04/25
11:46
04/25/17
11:46
Hot Stocks
Breaking Hot Stocks news story on McDonald's »

McDonald's says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 31

    May

SIG

Signet Jewelers

$66.12

0.02 (0.03%)

11:39
04/25/17
04/25
11:39
04/25/17
11:39
Periodicals
Greenlight closed short position in Signet Jewelers in Q1, Bloomberg reports »

Bloomberg cites the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:37
04/25/17
04/25
11:37
04/25/17
11:37
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

MDT

Medtronic

$81.70

1.05 (1.30%)

11:36
04/25/17
04/25
11:36
04/25/17
11:36
Hot Stocks
Medtronic announces outcomes from VeClose trial and data from WAVES study »

Medtronic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 06

    Jun

11:36
04/25/17
04/25
11:36
04/25/17
11:36
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

11:36
04/25/17
04/25
11:36
04/25/17
11:36
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

PRGO

Perrigo

$66.12

-0.93 (-1.39%)

11:35
04/25/17
04/25
11:35
04/25/17
11:35
Periodicals
Einhorn's Greenlight reveals new stake in Perrigo, Bloomberg reports »

Bloomberg cites the Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
04/25/17
04/25
11:35
04/25/17
11:35
General news
Treasury Option Action: a round of put buying on bonds »

Treasury Option Action: a…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.